DIRECTA PLUS PLC

Regulatory Filings • Dec 20, 2021

National Storage Mechanism | Additional information

RNS Number : 1178W

Directa Plus PLC

20 December 2021

20 December 2021

Directa Plus plc

("Directa Plus" or the "Company")

Grant of EU Patent for Shoe Soles

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company has been granted an EU-wide patent covering the use of the Company's G+® pristine graphene nanoplatelets to boost the performance of rubber-based shoe outsoles.  The priority date for the patent is July 2018.

The patent, titled "Shoe sole comprising graphene", covers G+® graphene embedded in outsoles.  The specific formulation of G+® graphene for soles provides the ability to balance opposite performance characteristics such as durability and grip, in both dry and wet conditions.  This ability to balance opposing performance traits is unique to Directa Plus's G+® graphene and becomes markedly apparent on rubber-based technical shoe soles such as those used for running, trail running, hiking, and on motorbikes.  The patent covers both the formula for the compound and the final product outsole made with the compound.

Following the grant of the patent, Directa Plus's IP portfolio will comprise 18 patent families with 72 patents granted and 25 patents pending.

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "This EU patent will reinforce our position in the fast-growing market for technical footwear, attracting the attention of the major consumer product players.  We will continue to aggressively expand our IP portfolio, covering both production technology and applications, to continue to build value for shareholders."

For further information please visit http://www.directa-plus.com/ or contact:

Directa Plus plc	+39 02 36714458
Giulio Cesareo, CEO / Giorgio Bonfanti, CFO
Cenkos Securities plc (Nominated Adviser and Joint Broker)	+44 131 220 6939
Neil McDonald / Adam Rae
Singer Capital Markets (Joint Broker)	+44 20 7496 3069
Rick Thompson / Phil Davies
Tavistock (Financial PR and IR)	+44 20 7920 3150
Simon Hudson / Heather Armstrong

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

-ends-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAEANANFSFFFFA